-
-
Call more information
660-596-2224 -
ASA Monitor December 2024, Vol. 88, 28–29. FDA approves Exact Sciences’ Cologuard Plus test Exact Sciences Corp., a leading provider of cancer screening and diagnostic tests, today announced the U.S. Food and Drug Administration (FDA) approved the Cologuard Plus™ test, the company’s next generation multitarget stool DNA test. The Cologuard Plus test is now approved for […]
Read MoreAuthor: Robin Hocevar ASA Monitor December 2024, Vol. 88, 32. One surefire way to start a lively conversation among anesthesiologists is to bring up the ideal timeline children should fast before surgery. This clinical controversy was the focus of a point-counterpoint discussion at ANESTHESIOLOGY® 2024. Joelle Karlik, MD, Pediatric Anesthesia and Pain Medicine, Children’s Healthcare of Atlanta-Arthur […]
Read MoreASA Monitor December 2024, Vol. 88, 25. Medical malpractice statistics are sobering. One in three providers will be sued over the course of their career (StatPearls. 2024). The annual overall rate of paid malpractice claims among all specialties is 14.1 per 1,000 physician-years (JAMA Intern Med 2017;177:710-8). Anesthesiologists experience an annual rate of paid malpractice claims of […]
Read MoreAuthor: Kim Sumrak ASA Monitor December 2024, Vol. 88, e9. Infertility affects one in eight couples in the general population and one in four female physicians. Many are unaware of these statistics, even in the medical community. When faced with infertility, there is an enormous emotional, physical, and even financial toll. While there is not a […]
Read MoreAuthors: Sachin “Sunny” Jha, MD, MS, FASA; Robert Carter, III, Colonel (U.S. Army), PhD ASA Monitor December 2024, Vol. 88, e4–e7. In an era marked by evolving biothreats and emerging infectious diseases, the U.S. biodefense apparatus has become a critical component of national security. As key players in the health care system, anesthesiologists have a pivotal role […]
Read More